Omeprazole: an exploration of its reported genotoxicity

Related Experiment Videos

H S Rosenkranz1, G Klopman

  • 1Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, PA 15261.

Mutagenesis
|September 1, 1991
PubMed

Insights

Omeprazole, an anti-ulcer drug, may be a genotoxic carcinogen due to its unstable sulphenimide metabolite. Further computer-based analysis supports concerns about its potential mutagenicity and genotoxicity in rodents.

Area of Science:

  • Pharmacology
  • Toxicology
  • Molecular Biology

Background:

  • The safety of omeprazole, a widely used anti-ulcer medication, is debated due to its potential to induce unscheduled DNA synthesis in gastric mucosa.
  • Concerns exist regarding the mutagenicity, genotoxicity, and carcinogenicity of omeprazole, particularly in rodent models.

Purpose of the Study:

  • To conduct a detailed computer-based investigation into the structural basis of omeprazole's putative mutagenicity, genotoxicity, and carcinogenicity.
  • To evaluate the role of the sulphenimide metabolite in these potential adverse effects.

Main Methods:

  • Utilized computer-based analysis to study the chemical structure of omeprazole and its sulphenimide metabolite.
  • Assessed the structural features associated with potential genotoxic and carcinogenic activities.

Main Results:

  • The study concluded that omeprazole is a potential genotoxic carcinogen.
  • Structural analysis indicated that the unstable sulphenimide metabolite is likely associated with these genotoxic and carcinogenic activities.

Conclusions:

  • Omeprazole's potential genotoxicity and carcinogenicity are linked to its sulphenimide metabolite.
  • The findings warrant further investigation into the long-term safety of omeprazole, especially concerning its genotoxic potential.

Related Concept Videos